Journal of Clinical Microbiology, March 1999, p. 649-652, Vol. 37, No. 3
0095-1137/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.
DIESSE Diagnostica Senese Srl,
Received 23 July 1998/Returned for modification 5 October
1998/Accepted 18 November 1998
A recombinant enzyme immunoassay (rEIA) to detect serum
immunoglobulin M (IgM) and IgG to Toscana virus (TOSV) was developed with the aim of establishing a simple and easily available assay for
diagnosing acute and/or previous infections. The rEIA, based on the
recombinant nucleoprotein of TOSV expressed in Escherichia coli, was evaluated with 97 serum samples collected in an area where TOSV is endemic and compared to an analogous assay based on
cell-derived TOSV. Discordant results were resolved by immunoblotting (IB). Twenty-two of these samples, obtained from subjects hospitalized during the summer season with meningitis of suspected TOSV etiology, were further characterized by indirect immunofluorescence and IB, and
detection of specific TOSV RNA sequences in the cerebrospinal fluid of
these patients was attempted by nested PCR. The results indicated that
rEIA was able to diagnose acute TOSV infection by detection of specific
serum IgM in all of the subjects with TOSV meningitis confirmed by
nested PCR or serology. The overall sensitivity and specificity of rEIA
were both 100% for IgM detection and 100 and 96.6%, respectively, for
IgG detection. Thus, rEIA appears to be a simple and reliable
laboratory test for the diagnosis of acute TOSV infection and for the
assessment of immune status.
*
Corresponding author. Mailing address: DIESSE
Diagnostica Senese Srl, Via delle Rose 10, 53035 Monteriggioni (SI),
Italy. Phone: 0039-577-587111. Fax: 0039-577-318690. E-mail:
Diesssi{at}tin.it.
This article has been cited by other articles:
| Antimicrob. Agents Chemother. | Clin. Microbiol. Rev. |
|---|---|
| Clin. Vaccine Immunol. | ALL ASM JOURNALS |
|---|